Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-interferon plus methylprednisolone versus beta-interferon in hospitalized adults with COVID-19
IRCT20200825048514N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- May 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of interferon beta-1a and methylprednisolone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Body temperature, Blood pressure and 8 more. Started May 2020; status: completed.
02
Drugs
interferon beta-1amethylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200825048514N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048514N1.